+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2019

  • PDF Icon

    Report

  • 101 Pages
  • December 2019
  • Region: Global
  • GlobalData
  • ID: 4898179
Description Jump to:
Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2019“ provides an overview of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Introduction
1.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview
2 Products under Development
2.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
2.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
2.3 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
2.4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
2.5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
3 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products under Development by Companies
3.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development
3.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview
4.1 Boston Scientific Corp Company Overview
4.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.2 Mayo Clinic Company Overview
4.2.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
4.3 Medtronic plc Company Overview
4.3.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
4.4 MicroPort CRM Company Overview
4.4.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
4.5 St. Jude Medical LLC Company Overview
4.5.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
4.6 Teleflex Inc Company Overview
4.6.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments
5.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
5.2 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook
5.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
5.4 Nov 12, 2019: T2 Biosystems reports third quarter 2019 financial highlights and provides corporate update
5.5 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue
6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
Table 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
Table 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
Table 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
Table 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
Table 6: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development
Table 7: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Status
Table 10: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Description
Table 11: Next Generation ICD Lead - Product Status
Table 12: Next Generation ICD Lead - Product Description
Table 13: X4 SYSTEM + QUAD LEAD - Product Status
Table 14: X4 SYSTEM + QUAD LEAD - Product Description
Table 15: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Epicardial Pacing/sensing Lead - Product Status
Table 17: Epicardial Pacing/sensing Lead - Product Description
Table 18: Pacemaker/ICD Lead - Product Status
Table 19: Pacemaker/ICD Lead - Product Description
Table 20: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Attain Stability Quad MRI SureScan - Product Status
Table 22: Attain Stability Quad MRI SureScan - Product Description
Table 23: Medtronic plc - Ongoing Clinical Trials Overview
Table 24: Attain Stability Quad MRI SureScan - Attain Stability Quad Clinical Study
Table 25: Attain Stability Quad MRI SureScan - Personalized CRT - Attain Stability Quad Post-Approval Study
Table 26: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
Table 27: BonaFire - Active Pacing Lead - Product Status
Table 28: BonaFire - Active Pacing Lead - Product Description
Table 29: BonaFire - Passive Pacing Lead - Product Status
Table 30: BonaFire - Passive Pacing Lead - Product Description
Table 31: Nano Lead System - Product Status
Table 32: Nano Lead System - Product Description
Table 33: SonR Tist Lead Positioning - Product Status
Table 34: SonR Tist Lead Positioning - Product Description
Table 35: SonRFix Lead - Product Status
Table 36: SonRFix Lead - Product Description
Table 37: Tachy Lead - Product Status
Table 38: Tachy Lead - Product Description
Table 39: TX Brady Lead - Product Status
Table 40: TX Brady Lead - Product Description
Table 41: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Quartet NXT - Double Blend Lead - Product Status
Table 43: Quartet NXT - Double Blend Lead - Product Description
Table 44: Quartet NXT - Large S-Curve Lead - Product Status
Table 45: Quartet NXT - Large S-Curve Lead - Product Description
Table 46: Quartet NXT - Small S-Curve Lead - Product Status
Table 47: Quartet NXT - Small S-Curve Lead - Product Description
Table 48: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Pacemaker Lead - Product Status
Table 50: Pacemaker Lead - Product Description
Table 51: Glossary
List of Figures
Figure 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
Figure 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
Figure 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
Figure 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
Figure 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific Corp
  • Mayo Clinic
  • Medtronic plc
  • MicroPort CRM
  • St. Jude Medical LLC
  • Teleflex Inc

Related Topics

Related Reports

Cardiovascular Pacing and ICD Leads Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Image

Cardiovascular Pacing and ICD Leads Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • 75 Pages
  • Global
From
Global Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Implantable Cardioverter Defibrillator Market Size, Share & Industry Trends Analysis Report By Type, By Product Type, By NYHA Class, By End-Use (Hospitals, Ambulatory Surgical Centers), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Implantable Defibrillators - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Implantable Defibrillators - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Global Implantable Cardioverter Defibrillators Market Size, Share & Trends Analysis Report by NYHA Class (NYHA Class I, NYHA Class II), End-use (Hospitals, Ambulatory Surgical Centers), Product Type, Type, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Implantable Cardioverter Defibrillators Market Size, Share & Trends Analysis Report by NYHA Class (NYHA Class I, NYHA Class II), End-use (Hospitals, Ambulatory Surgical Centers), Product Type, Type, Region, and Segment Forecasts, 2024-2030

  • Report
  • 174 Pages
  • Global
From
Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.